VITR Stock Overview
Provides assisted reproduction products. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VITR from our risk checks.
Vitrolife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 214.00 |
| 52 Week High | SEK 268.00 |
| 52 Week Low | SEK 156.00 |
| Beta | 1.8 |
| 1 Month Change | -9.93% |
| 3 Month Change | -13.64% |
| 1 Year Change | 13.53% |
| 3 Year Change | -58.37% |
| 5 Year Change | 10.03% |
| Change since IPO | 2,914.08% |
Recent News & Updates
Recent updates
Is Vitrolife (STO:VITR) A Risky Investment?
Nov 27
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Aug 21Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Jul 20Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth
Jul 18Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Mar 07Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now
Feb 05Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion
Jan 05Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching
Dec 15Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Nov 27Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued
Aug 25Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?
May 26Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Sep 09Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
May 26Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly
Mar 31Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Feb 07Shareholder Returns
| VITR | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | -0.4% | 0.4% | -0.9% |
| 1Y | 13.5% | 16.4% | 8.9% |
Return vs Industry: VITR underperformed the Swedish Biotechs industry which returned 18.9% over the past year.
Return vs Market: VITR matched the Swedish Market which returned 13% over the past year.
Price Volatility
| VITR volatility | |
|---|---|
| VITR Average Weekly Movement | 4.4% |
| Biotechs Industry Average Movement | 9.7% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: VITR has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: VITR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 1,111 | Bronwyn Brophy O´Connor | www.vitrolife.com |
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems.
Vitrolife AB (publ) Fundamentals Summary
| VITR fundamental statistics | |
|---|---|
| Market cap | SEK 28.97b |
| Earnings (TTM) | -SEK 3.80b |
| Revenue (TTM) | SEK 3.56b |
8.2x
P/S Ratio-7.6x
P/E RatioIs VITR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VITR income statement (TTM) | |
|---|---|
| Revenue | SEK 3.56b |
| Cost of Revenue | SEK 1.49b |
| Gross Profit | SEK 2.07b |
| Other Expenses | SEK 5.87b |
| Earnings | -SEK 3.80b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | -28.10 |
| Gross Margin | 58.17% |
| Net Profit Margin | -107.03% |
| Debt/Equity Ratio | 14.6% |
How did VITR perform over the long term?
See historical performance and comparison